Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · IEX Real-Time Price · USD
9.85
+0.05 (0.51%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Amicus Therapeutics Employees
Amicus Therapeutics had 517 employees as of December 31, 2023. The number of employees increased by 33 or 6.82% compared to the previous year.
Employees
517
Change (1Y)
33
Growth (1Y)
6.82%
Revenue / Employee
$819,128
Profits / Employee
-$284,470
Market Cap
2.92B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 517 | 33 | 6.82% |
Dec 31, 2022 | 484 | -12 | -2.42% |
Dec 31, 2021 | 496 | 13 | 2.69% |
Dec 31, 2020 | 483 | -101 | -17.29% |
Dec 31, 2019 | 584 | 76 | 14.96% |
Dec 31, 2018 | 508 | 183 | 56.31% |
Dec 31, 2017 | 325 | 62 | 23.57% |
Dec 31, 2016 | 263 | 78 | 42.16% |
Dec 31, 2015 | 185 | 88 | 90.72% |
Dec 31, 2014 | 97 | 5 | 5.43% |
Dec 31, 2013 | 92 | -20 | -17.86% |
Dec 31, 2012 | 112 | 16 | 16.67% |
Dec 31, 2011 | 96 | -3 | -3.03% |
Dec 31, 2010 | 99 | 2 | 2.06% |
Dec 31, 2009 | 97 | -18 | -15.65% |
Dec 31, 2008 | 115 | 24 | 26.37% |
Dec 31, 2007 | 91 | 14 | 18.18% |
Dec 31, 2006 | 77 | 25 | 48.08% |
Dec 31, 2005 | 52 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Amedisys | 19,000 |
ICU Medical | 14,000 |
Envista Holdings | 12,800 |
Azenta | 3,500 |
LivaNova | 2,900 |
HUTCHMED (China) | 1,988 |
Twist Bioscience | 919 |
GoodRx Holdings | 694 |
FOLD News
- 1 day ago - In NCLA Amicus Win, Supreme Court Upholds Small Business's Right to Judicial Review - GlobeNewsWire
- 5 days ago - In NCLA Amicus Win, Supreme Court Restores Americans' Rights to Trial by Jury - GlobeNewsWire
- 6 days ago - In NCLA Amicus Win, Fifth Circuit Upholds Permanent Block on Treasury's Illegal State Tax Cut Ban - GlobeNewsWire
- 19 days ago - In NCLA Amicus Win, Supreme Court Overturns NLRB-Specific Preliminary Injunction Standard - GlobeNewsWire
- 21 days ago - In NCLA Amicus Win, Tenth Circuit Clears Path to Toppling Intrusive Dog Kennel Inspection Regime - GlobeNewsWire
- 27 days ago - In NCLA Amicus Win, Fifth Circuit Topples SEC's Unlawful Effort to Regulate Private Funds - GlobeNewsWire
- 27 days ago - Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates - GlobeNewsWire